欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1562/002
药品名称CLARISCAN
活性成分
    • gadoteric acid 0.5 mmol/ml
剂型Solution for injection in prefilled syringe
上市许可持有人GE Healthcare AS, Norway
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      CLARISCAN 0,5 mmol/ml Injektionslösung in einer Fertigspritze
    • Slovenia (SI)
    • Italy (IT)
    • Romania (RO)
      CLARISCAN 0,5 mmoli/ml soluție injectabilă în seringă preumplută
    • Spain (ES)
    • Malta (MT)
      Clariscan 0.5mmol/ml solution for injection in pre-filled syringe
    • France (FR)
    • Croatia (HR)
      Clariscan 0,5 mmol/ml otopina za injekciju u napunjenoj štrcaljki
    • Austria (AT)
      Clariscan 0,5 mmol/ml Injektionslösung in einer Fertigspritze
    • Poland (PL)
      Clariscan
    • Ireland (IE)
    • Latvia (LV)
      Clariscan 0,5 mmol/ml šķīdums injekcijām pilnšļircē
    • United Kingdom (Northern Ireland) (XI)
    • Lithuania (LT)
      Clariscan 0,5 mmol/ml injekcinis tirpalas užpildytame švirkšte
    • Iceland (IS)
      CLARISCAN 0,5 mmól/ml Stungulyf, lausn í áfylltri sprautu
    • Hungary (HU)
      CLARISCAN 0,5 mmol/ml oldatos injekció előretöltött fecskendőben
    • Denmark (DK)
      Clariscan
    • Estonia (EE)
      CLARISCAN
    • Czechia (CZ)
      Clariscan 0,5 mmol/mL, Injekční roztok v předplněné injekční stříkačce
    • Bulgaria (BG)
      Clariscan
    • Portugal (PT)
    • Luxembourg (LU)
    • Greece (GR)
    • Netherlands (NL)
      Clariscan 0,5 mmol/mL, oplossing voor injectie in voorgevulde spuit
    • Belgium (BE)
    • Finland (FI)
    • Slovakia (SK)
    • Norway (NO)
      Clariscan
许可日期2017/01/24
最近更新日期2024/02/08
药物ATC编码
    • V08CA02 gadoteric acid
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase